Prices delayed by at least 15 minutes | Print
Proteome Sciences PLC (PRM)
ORD 1POpen
4.3224p
Previous close
3.51p
Trade high
4.644p
Volume
123,867
Year high
8.79p
Year low
2.65p
Dividend yield
-
Market capitalisation
£11.07 mn
P/E ratio
17.43
ISIN
GB0003104196
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
26/04/2024 | 12:27:32 | 3.75 | 2,175 | 81.56 |
26/04/2024 | 12:05:24 | 4.5899 | 2,500 | 114.75 |
26/04/2024 | 09:38:15 | 4.5899 | 21,700 | 996.01 |
26/04/2024 | 09:09:11 | 4.644 | 50,000 | 2,322.00 |
26/04/2024 | 08:51:37 | 4.24 | 47,169 | 1,999.97 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.